USP drug classification [BR:br08302]
Cardiovascular Agents
Dyslipidemics, Other
Icosapent Ethyl
D01892 Icosapent ethyl (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
218 Hyperlipidemia agents
2189 Others
D01892 Icosapent ethyl (USAN); Ethyl icosapentate (JP18)
3 Agents affecting metabolism
33 Blood and body fluid agents
339 Miscellaneous
3399 Others
D01892 Icosapent ethyl (USAN); Ethyl icosapentate (JP18)
Classification of Japanese OTC drugs [BR:br08313]
Agents for circulatory system and blood
25 Other drugs for circulatory system and blood
D01892 Icosapent ethyl (USAN)
Other (not belonging to any other category)
85 Other (not belonging to any other category)
D01892 Icosapent ethyl (USAN)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Ethyl icosapentate
D01892 Icosapent ethyl (USAN)
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
D01892 Icosapent ethyl
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
D01892 Icosapent ethyl
Drug classes [BR:br08332]
Cardiovascular agent
DG01946 Hypolipidemic agent
D01892 Icosapent ethyl
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01892 Ethyl icosapentate
D01892 Ethyl icosapentate capsules
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D01892
Rx-to-OTC switch list in Japan [br08314.html]
D01892